Link copied to clipboard!

Lilavati Hospital to expand its global presence

IMT News Desk
IMT News Desk
· Updated Aug 12, 2026 · 3 min read

Lilavati Hospital is set to launch its super-speciality OPD facility in Kazakhstan from early September 2026.

Lilavati Hospital, one of India’s most recognised healthcare institutions, is set to expand its international presence with the launch of a super-speciality OPD facility in Kazakhstan from early September 2026. The initiative marks an important step in Lilavati Hospital’s long-term vision of taking its trusted healthcare expertise beyond India and building a strong international healthcare presence. 

The Kazakhstan initiative, the first Lilavati healthcare facility outside India to become operational, will bring Lilavati Hospital’s specialist consultations, second opinions, advanced treatment planning and medical expertise closer to patients in Central Asia. The centre will offer super-speciality services across Oncology, Liver and Hepatobiliary, Kidney and Transplantation, Cardiac Sciences, Neurology and Neurosurgery, IVF and Reproductive Medicine, Gastroenterology, Orthopaedics, Urology, Endocrinology and Diabetes, Paediatrics and Pulmonology. Complex cases requiring advanced treatment and surgery will be connected with Lilavati Hospital Mumbai. 

With more than three decades of healthcare experience, Lilavati Hospital brings a strong foundation of clinical expertise to this expansion. The hospital has around 375 experienced consultants and specialists in more than 40 medical and surgical specialties, including transplantation, oncology, cardiac sciences, neurosciences, robotic and minimally invasive surgery, GI and hepatobiliary surgery, and IVF. 

The hospital is also pursuing its international expansion with a focus on building a strong healthcare ecosystem, especially in the Commonwealth of Independent States (CIS) and beyond, under the stewardship of Smt Charuben Mehta, Founder, Permanent Trustee for Life & Chairperson, Lilavati Hospital.  

Dr. Ravindra Karanjekar, CEO of Lilavati Hospital and Research Centre, said, “Our expansion into Kazakhstan is an important step in our vision of taking trusted Indian healthcare expertise to the world. We want to bring Lilavati’s clinical expertise, specialist consultations and advanced treatment pathways closer to patients in Central Asia. At the same time, this initiative is about building a sustainable India–Kazakhstan healthcare ecosystem through specialist consultations, telemedicine, medical education and doctor-to-doctor collaboration. For complex cases, patients will have a structured pathway to access advanced care at Lilavati Hospital Mumbai. We see Kazakhstan as the first step to building our presence across the wider Central Asian region.” 

The initiative will also see a boost to local employment, while maintaining Lilavati Hospital’s clinical protocols and standards. The Kazakhstan centre will serve as a gateway to Lilavati Hospital’s wider expansion across Central Asia and other international markets. 

Read Next

NephroPlus launches International Dialysis Academy
News
September 11, 2026

NephroPlus launches International Dialysis Academy

A dedicated initiative designed to prepare nursing graduates in India and the Philippines for specialized careers in dialysis care and international deployment.  NephroPlus, Asia’s largest dialysis network, announced the launch of the NephroPlus International Dialysis Academy (NIDA), a dedicated initiative designed to prepare nursing graduates in India and the Philippines for specialized careers in dialysis care and international deployment. The first NIDA […]
Article by: IMT News Desk
Fortis to Install India’s First Upright Proton Therapy System
News
September 9, 2026

Fortis to Install India’s First Upright Proton Therapy System

The advanced MEVION S250-FIT, Proton Therapy System will help advance precision cancer care. Fortis Healthcare, part of the IHH Healthcare group, today announced plans to install the MEVION S250-FIT, Proton Therapy System from Mevion Medical Systems at Fortis Memorial Research Institute (FMRI), Gurugram, its flagship quaternary-care hospital and a leading centre for comprehensive oncology and precision cancer care.  Featuring Leo Cancer […]
Article by: IMT News Desk
Wadi Surgicals launches Enliva Active
News
September 2, 2026

Wadi Surgicals launches Enliva Active

Strengthening India’s glove manufacturing sector through the vision of Atmanirbhar Bharat.  Wadi Surgicals Pvt. Ltd., owner of the Enliva nitrile glove brand, has partnered with Hubertus Medical Products Pvt. Ltd., Andhra Pradesh to launch Enliva Active, a black, food-safe nitrile glove developed specifically for the HoReCa (Hotels, Restaurants and Catering) sector.  India’s foodservice industry is one of the country’s fastest-growing consumer sectors. […]
Article by: IMT News Desk
Yashoda Medicity Signs MoU with the Republic of Kazakhstan
News
September 1, 2026

Yashoda Medicity Signs MoU with the Republic of Kazakhstan

The MoU is set to facilitate access to specialized and quaternary care in India, clinical training and knowledge exchange for healthcare professionals from Turkistan. Yashoda Medicity, a leading healthcare institution in Delhi-NCR, has signed a Memorandum of Understanding (MoU) with the Republic of Kazakhstan, Turkistan City, to establish a structured framework for cooperation in advanced medical care, patient referrals, healthcare […]
Article by: IMT News Desk